The influenza immunisation rate for persons aged 65+ in Norway is projected to increase steadily from 64.4% in 2024 to 77.4% in 2028. Comparing the forecasts for 2025 and 2024, there is an anticipated year-on-year increase of 5.12%. Between 2026 and 2025, the growth is expected to reach 4.88%. For the period from 2027 to 2026, the rate of increase is projected to be 4.51%, while the predicted growth between 2028 and 2027 stands at 4.31%. Analyzing the compound annual growth rate (CAGR) from 2023 to 2028, the average annual increase is expected to be 4.7%.
Future trends to watch for include advancements in vaccine technology, higher public awareness, and government-driven healthcare initiatives aimed at increasing immunisation coverage among the elderly population. These factors could accelerate the growth rate beyond current projections.
